MedTrace Logo

Tigecycline In-Vitro Surveillance Study In Taiwan

NCT00488397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7902

Last updated 2011-03-22

No results posted yet for this study

Summary

In-vitro surveillance study of tigecycline (Tygacil) in Taiwan.

Conditions

  • Community Acquired Infections

Interventions

OTHER

In-vitro testing

This is an in-vitro study thus only one group in the study and there is no intervention treatment nor procedure involved in this study.

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00488397 on ClinicalTrials.gov